Juniper Pharma (JNP) Tops Q3 EPS by 14c

Juniper Pharma (NASDAQ: JNP) reported Q3 EPS of $0.09, $0.14 better than the analyst estimate of ($0.05). Revenue for the quarter came in at $11.5 million versus the consensus estimate of $7.1 million.

For earnings history and earnings-related data on Juniper Pharma (JNP) click here.

You May Also Be Interested In

• JPMorgan Upgrades Aviva Plc (AV/:LN) (AIVAF) to Overweight
• Mannatech (MTEX) Tops Q2 EPS by 53c
• North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance